<h1>Platinum Poppy's Acquisition of Shares in Berhyanda Approved, Gains Indirect Stake in Suven Pharmaceuticals.</h1> The Competition Commission of India has approved Platinum Poppy's acquisition of ordinary shares in Berhyanda Limited and Berhyanda MidCo Limited. This transaction grants Platinum Poppy an indirect non-voting economic interest in Suven Pharmaceuticals Limited, as Berhyanda holds a 50.1% stake in Suven. Platinum Poppy, a company established in the Abu Dhabi Global Market, is ultimately owned by the Abu Dhabi Investment Authority, which manages a diverse global investment portfolio. Berhyanda and Berhyanda MidCo are investment holding companies owned by Advent International. Suven Pharmaceuticals, listed in India, manufactures and sells pharmaceutical ingredients and intermediates.